Research indicates that RNase L is associated with acute lung injury, acute ischemic heart damage, prostate cancer, colorectal cancer, and breast cancer [36], demonstrating that the role of OAS-RNase L extends beyond antiviral responses. This evidence concerns the gene SMOC1 and prostate cancer.